EA200200545A1 - Онколитические комбинации для лечения рака - Google Patents

Онколитические комбинации для лечения рака

Info

Publication number
EA200200545A1
EA200200545A1 EA200200545A EA200200545A EA200200545A1 EA 200200545 A1 EA200200545 A1 EA 200200545A1 EA 200200545 A EA200200545 A EA 200200545A EA 200200545 A EA200200545 A EA 200200545A EA 200200545 A1 EA200200545 A1 EA 200200545A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer treatment
oncolytic
combinations
oncolytic combinations
ltb
Prior art date
Application number
EA200200545A
Other languages
English (en)
Russian (ru)
Inventor
Джером Герберт Флейш
Роджер Стюарт Бенджамин
Джейсон Скотт Сойер
Беверли Энн Тейчер
Дуглас Вэйд Бэйт
Эдвард К. Р. Смит
Вилльям Томас Макмиллен
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200200545A1 publication Critical patent/EA200200545A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EA200200545A 1999-11-11 2000-11-09 Онколитические комбинации для лечения рака EA200200545A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16478699P 1999-11-11 1999-11-11
PCT/US2000/031039 WO2001034137A2 (en) 1999-11-11 2000-11-09 Oncolytic combinations for the treatment of cancer

Publications (1)

Publication Number Publication Date
EA200200545A1 true EA200200545A1 (ru) 2002-12-26

Family

ID=22596085

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200545A EA200200545A1 (ru) 1999-11-11 2000-11-09 Онколитические комбинации для лечения рака

Country Status (22)

Country Link
EP (1) EP1231938A2 (xx)
JP (1) JP2003513916A (xx)
KR (1) KR20020069512A (xx)
CN (1) CN1390139A (xx)
AR (1) AR032432A1 (xx)
AU (1) AU778829B2 (xx)
BR (1) BR0015490A (xx)
CA (1) CA2391416A1 (xx)
CZ (1) CZ20021551A3 (xx)
EA (1) EA200200545A1 (xx)
HK (1) HK1050132A1 (xx)
HU (1) HUP0204449A3 (xx)
IL (1) IL148579A0 (xx)
MX (1) MXPA02004733A (xx)
NO (1) NO20022245L (xx)
NZ (1) NZ517667A (xx)
PE (1) PE20010701A1 (xx)
PL (1) PL355172A1 (xx)
SK (1) SK6492002A3 (xx)
TR (1) TR200201245T2 (xx)
WO (1) WO2001034137A2 (xx)
ZA (1) ZA200202822B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1916501A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6797723B1 (en) 1999-11-11 2004-09-28 Eli Lilly And Company Heterocycle substituted diphenyl leukotriene antagonists
AU1916601A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
JP2001247459A (ja) 2000-03-03 2001-09-11 Oakland Uniservices Ltd 癌の組み合わせ療法
CN1237968C (zh) * 2000-05-09 2006-01-25 克赖顿大学 抑制癌细胞的增殖和诱导其凋亡的方法
JP2004505047A (ja) 2000-07-28 2004-02-19 キャンサー・リサーチ・テクノロジー・リミテッド 複合治療による癌治療
GB0121285D0 (en) 2001-09-03 2001-10-24 Cancer Res Ventures Ltd Anti-cancer combinations
GB2386836B (en) 2002-03-22 2006-07-26 Cancer Res Ventures Ltd Anti-cancer combinations
GB2394658A (en) 2002-11-01 2004-05-05 Cancer Rec Tech Ltd Oral anti-cancer composition
EP1745014B1 (en) 2004-05-05 2011-07-06 High Point Pharmaceuticals, LLC Novel compounds, their preparation and use
JP2007536343A (ja) 2004-05-05 2007-12-13 ノボ　ノルディスク　アクティーゼルスカブ Ｐｐａｒアゴニストとしてのフェノキシ酢酸誘導体
CN1302782C (zh) * 2005-01-17 2007-03-07 北京京卫燕康药物研究所有限公司 盐酸吉西他滨溶液型注射剂
ATE529404T1 (de) 2005-06-30 2011-11-15 High Point Pharmaceuticals Llc Phenoxyessigsäuren als ppar-delta-aktivatoren
EA015717B1 (ru) 2005-12-22 2011-10-31 ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи Феноксиуксусные кислоты в качестве активаторов ppar дельта
EP1999098A2 (en) 2006-03-09 2008-12-10 High Point Pharmaceuticals, LLC Compounds that modulate ppar activity, their preparation and use
US8044236B2 (en) 2006-10-12 2011-10-25 Institute Of Medicinal Molecular Design, Inc. Carboxilic acid derivatives
US8633245B2 (en) 2008-04-11 2014-01-21 Institute Of Medicinal Molecular Design, Inc. PAI-1 inhibitor
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
CN104884449A (zh) 2012-10-31 2015-09-02 拜尔农作物科学股份公司 作为害虫防治剂的新的杂环化合物
CN103319466B (zh) * 2013-07-04 2016-03-16 郑州大学 含香豆素母核的1,2,3-三唑-氨基二硫代甲酸酯化合物、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation

Also Published As

Publication number Publication date
CA2391416A1 (en) 2001-05-17
NZ517667A (en) 2004-05-28
WO2001034137A3 (en) 2002-02-14
KR20020069512A (ko) 2002-09-04
HK1050132A1 (zh) 2003-06-13
CZ20021551A3 (cs) 2003-02-12
AU1599001A (en) 2001-06-06
MXPA02004733A (es) 2002-08-30
WO2001034137A2 (en) 2001-05-17
AU778829B2 (en) 2004-12-23
CN1390139A (zh) 2003-01-08
NO20022245D0 (no) 2002-05-10
HUP0204449A2 (hu) 2003-04-28
PL355172A1 (en) 2004-04-05
TR200201245T2 (tr) 2004-08-23
EP1231938A2 (en) 2002-08-21
NO20022245L (no) 2002-07-09
BR0015490A (pt) 2002-07-09
IL148579A0 (en) 2002-09-12
AR032432A1 (es) 2003-11-12
PE20010701A1 (es) 2001-07-07
ZA200202822B (en) 2003-09-23
HUP0204449A3 (en) 2006-02-28
SK6492002A3 (en) 2003-09-11
JP2003513916A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
EA200200545A1 (ru) Онколитические комбинации для лечения рака
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
PT1193270E (pt) Pirrolobenzodiazepinas
CR6540A (es) Trifluorobutenos nematicidas
EA200101046A1 (ru) Производные индигоидных бис-индолов
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
EA200300566A1 (ru) Применение cci-779 в качестве противоопухолевого средства
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
FI902555A0 (fi) Diarylstyrylkinolindisyror.
SE9901077D0 (sv) Novel use
BR0109542A (pt) Derivados de imidazopirina alquilados
EA200400475A1 (ru) Замещенные производные бензимидазола и их применение для лечения злокачественной опухоли
SE9801494D0 (sv) Novel use
ATE201204T1 (de) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
BR9902084A (pt) Heterociclos.
WO2001034198A3 (en) Oncolytic combinations for the treatment of cancer
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
AR022321A1 (es) Derivados de anticonvulsivo utiles para el tratamiento de la migrana transformada
BR0012751A (pt) Benzofuranos serotonérgicos
TR199901017A2 (xx) B�cek ilac� terkibi.
WO2001034134A3 (en) Oncolytic combinations for the treatment of cancer
BR0017046A (pt) Uso de azóis para prevenção de câncer de pele
PT1244614E (pt) Inibidores de triptase